Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Inactivated Poultry Vaccine Market Growth 2022-2028

  • LP 4935476
  • 117 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Inactivated Poultry Vaccine will have significant change from previous year. According to our (LP Information) latest study, the global Inactivated Poultry Vaccine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Inactivated Poultry Vaccine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Inactivated Poultry Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Inactivated Poultry Vaccine market, reaching US$ million by the year 2028. As for the Europe Inactivated Poultry Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Inactivated Poultry Vaccine players cover Zoetis, Merck Animal Health, Boehringer Ingelheim, and Elanco Animal Health, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Inactivated Poultry Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Liquid Vaccines

Freeze-Dried Vaccines

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Avian Encephalomyelitis

Chicken Anaemia

Egg Drop Syndrome

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Zoetis

Merck Animal Health

Boehringer Ingelheim

Elanco Animal Health

Phibro Animal Health

Virbac

Hipra

Venkys

Biovet

Ringpu Biology

Ceva Corporate

KM Biologics

Vaxxinova

Japfa Comfeed Indonesia

Nisseiken

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Inactivated Poultry Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Inactivated Poultry Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Inactivated Poultry Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Inactivated Poultry Vaccine Segment by Type

2.2.1 Liquid Vaccines

2.2.2 Freeze-Dried Vaccines

2.3 Inactivated Poultry Vaccine Sales by Type

2.3.1 Global Inactivated Poultry Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Inactivated Poultry Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Inactivated Poultry Vaccine Sale Price by Type (2017-2022)

2.4 Inactivated Poultry Vaccine Segment by Application

2.4.1 Avian Encephalomyelitis

2.4.2 Chicken Anaemia

2.4.3 Egg Drop Syndrome

2.4.4 Others

2.5 Inactivated Poultry Vaccine Sales by Application

2.5.1 Global Inactivated Poultry Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Inactivated Poultry Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Inactivated Poultry Vaccine Sale Price by Application (2017-2022)

3 Global Inactivated Poultry Vaccine by Company

3.1 Global Inactivated Poultry Vaccine Breakdown Data by Company

3.1.1 Global Inactivated Poultry Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Inactivated Poultry Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Inactivated Poultry Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Inactivated Poultry Vaccine Revenue by Company (2020-2022)

3.2.2 Global Inactivated Poultry Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Inactivated Poultry Vaccine Sale Price by Company

3.4 Key Manufacturers Inactivated Poultry Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Inactivated Poultry Vaccine Product Location Distribution

3.4.2 Players Inactivated Poultry Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Inactivated Poultry Vaccine by Geographic Region

4.1 World Historic Inactivated Poultry Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Inactivated Poultry Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Inactivated Poultry Vaccine Annual Revenue by Geographic Region

4.2 World Historic Inactivated Poultry Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Inactivated Poultry Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Inactivated Poultry Vaccine Annual Revenue by Country/Region

4.3 Americas Inactivated Poultry Vaccine Sales Growth

4.4 APAC Inactivated Poultry Vaccine Sales Growth

4.5 Europe Inactivated Poultry Vaccine Sales Growth

4.6 Middle East & Africa Inactivated Poultry Vaccine Sales Growth

5 Americas

5.1 Americas Inactivated Poultry Vaccine Sales by Country

5.1.1 Americas Inactivated Poultry Vaccine Sales by Country (2017-2022)

5.1.2 Americas Inactivated Poultry Vaccine Revenue by Country (2017-2022)

5.2 Americas Inactivated Poultry Vaccine Sales by Type

5.3 Americas Inactivated Poultry Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Inactivated Poultry Vaccine Sales by Region

6.1.1 APAC Inactivated Poultry Vaccine Sales by Region (2017-2022)

6.1.2 APAC Inactivated Poultry Vaccine Revenue by Region (2017-2022)

6.2 APAC Inactivated Poultry Vaccine Sales by Type

6.3 APAC Inactivated Poultry Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Inactivated Poultry Vaccine by Country

7.1.1 Europe Inactivated Poultry Vaccine Sales by Country (2017-2022)

7.1.2 Europe Inactivated Poultry Vaccine Revenue by Country (2017-2022)

7.2 Europe Inactivated Poultry Vaccine Sales by Type

7.3 Europe Inactivated Poultry Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Inactivated Poultry Vaccine by Country

8.1.1 Middle East & Africa Inactivated Poultry Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Inactivated Poultry Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Inactivated Poultry Vaccine Sales by Type

8.3 Middle East & Africa Inactivated Poultry Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Inactivated Poultry Vaccine

10.3 Manufacturing Process Analysis of Inactivated Poultry Vaccine

10.4 Industry Chain Structure of Inactivated Poultry Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Inactivated Poultry Vaccine Distributors

11.3 Inactivated Poultry Vaccine Customer

12 World Forecast Review for Inactivated Poultry Vaccine by Geographic Region

12.1 Global Inactivated Poultry Vaccine Market Size Forecast by Region

12.1.1 Global Inactivated Poultry Vaccine Forecast by Region (2023-2028)

12.1.2 Global Inactivated Poultry Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Inactivated Poultry Vaccine Forecast by Type

12.7 Global Inactivated Poultry Vaccine Forecast by Application

13 Key Players Analysis

13.1 Zoetis

13.1.1 Zoetis Company Information

13.1.2 Zoetis Inactivated Poultry Vaccine Product Offered

13.1.3 Zoetis Inactivated Poultry Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Zoetis Main Business Overview

13.1.5 Zoetis Latest Developments

13.2 Merck Animal Health

13.2.1 Merck Animal Health Company Information

13.2.2 Merck Animal Health Inactivated Poultry Vaccine Product Offered

13.2.3 Merck Animal Health Inactivated Poultry Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Merck Animal Health Main Business Overview

13.2.5 Merck Animal Health Latest Developments

13.3 Boehringer Ingelheim

13.3.1 Boehringer Ingelheim Company Information

13.3.2 Boehringer Ingelheim Inactivated Poultry Vaccine Product Offered

13.3.3 Boehringer Ingelheim Inactivated Poultry Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Boehringer Ingelheim Main Business Overview

13.3.5 Boehringer Ingelheim Latest Developments

13.4 Elanco Animal Health

13.4.1 Elanco Animal Health Company Information

13.4.2 Elanco Animal Health Inactivated Poultry Vaccine Product Offered

13.4.3 Elanco Animal Health Inactivated Poultry Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Elanco Animal Health Main Business Overview

13.4.5 Elanco Animal Health Latest Developments

13.5 Phibro Animal Health

13.5.1 Phibro Animal Health Company Information

13.5.2 Phibro Animal Health Inactivated Poultry Vaccine Product Offered

13.5.3 Phibro Animal Health Inactivated Poultry Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Phibro Animal Health Main Business Overview

13.5.5 Phibro Animal Health Latest Developments

13.6 Virbac

13.6.1 Virbac Company Information

13.6.2 Virbac Inactivated Poultry Vaccine Product Offered

13.6.3 Virbac Inactivated Poultry Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Virbac Main Business Overview

13.6.5 Virbac Latest Developments

13.7 Hipra

13.7.1 Hipra Company Information

13.7.2 Hipra Inactivated Poultry Vaccine Product Offered

13.7.3 Hipra Inactivated Poultry Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Hipra Main Business Overview

13.7.5 Hipra Latest Developments

13.8 Venkys

13.8.1 Venkys Company Information

13.8.2 Venkys Inactivated Poultry Vaccine Product Offered

13.8.3 Venkys Inactivated Poultry Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Venkys Main Business Overview

13.8.5 Venkys Latest Developments

13.9 Biovet

13.9.1 Biovet Company Information

13.9.2 Biovet Inactivated Poultry Vaccine Product Offered

13.9.3 Biovet Inactivated Poultry Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Biovet Main Business Overview

13.9.5 Biovet Latest Developments

13.10 Ringpu Biology

13.10.1 Ringpu Biology Company Information

13.10.2 Ringpu Biology Inactivated Poultry Vaccine Product Offered

13.10.3 Ringpu Biology Inactivated Poultry Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Ringpu Biology Main Business Overview

13.10.5 Ringpu Biology Latest Developments

13.11 Ceva Corporate

13.11.1 Ceva Corporate Company Information

13.11.2 Ceva Corporate Inactivated Poultry Vaccine Product Offered

13.11.3 Ceva Corporate Inactivated Poultry Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Ceva Corporate Main Business Overview

13.11.5 Ceva Corporate Latest Developments

13.12 KM Biologics

13.12.1 KM Biologics Company Information

13.12.2 KM Biologics Inactivated Poultry Vaccine Product Offered

13.12.3 KM Biologics Inactivated Poultry Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 KM Biologics Main Business Overview

13.12.5 KM Biologics Latest Developments

13.13 Vaxxinova

13.13.1 Vaxxinova Company Information

13.13.2 Vaxxinova Inactivated Poultry Vaccine Product Offered

13.13.3 Vaxxinova Inactivated Poultry Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Vaxxinova Main Business Overview

13.13.5 Vaxxinova Latest Developments

13.14 Japfa Comfeed Indonesia

13.14.1 Japfa Comfeed Indonesia Company Information

13.14.2 Japfa Comfeed Indonesia Inactivated Poultry Vaccine Product Offered

13.14.3 Japfa Comfeed Indonesia Inactivated Poultry Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Japfa Comfeed Indonesia Main Business Overview

13.14.5 Japfa Comfeed Indonesia Latest Developments

13.15 Nisseiken

13.15.1 Nisseiken Company Information

13.15.2 Nisseiken Inactivated Poultry Vaccine Product Offered

13.15.3 Nisseiken Inactivated Poultry Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Nisseiken Main Business Overview

13.15.5 Nisseiken Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Inactivated Poultry Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Inactivated Poultry Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Liquid Vaccines

Table 4. Major Players of Freeze-Dried Vaccines

Table 5. Global Inactivated Poultry Vaccine Sales by Type (2017-2022) & (K Units)

Table 6. Global Inactivated Poultry Vaccine Sales Market Share by Type (2017-2022)

Table 7. Global Inactivated Poultry Vaccine Revenue by Type (2017-2022) & ($ million)

Table 8. Global Inactivated Poultry Vaccine Revenue Market Share by Type (2017-2022)

Table 9. Global Inactivated Poultry Vaccine Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Inactivated Poultry Vaccine Sales by Application (2017-2022) & (K Units)

Table 11. Global Inactivated Poultry Vaccine Sales Market Share by Application (2017-2022)

Table 12. Global Inactivated Poultry Vaccine Revenue by Application (2017-2022)

Table 13. Global Inactivated Poultry Vaccine Revenue Market Share by Application (2017-2022)

Table 14. Global Inactivated Poultry Vaccine Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Inactivated Poultry Vaccine Sales by Company (2020-2022) & (K Units)

Table 16. Global Inactivated Poultry Vaccine Sales Market Share by Company (2020-2022)

Table 17. Global Inactivated Poultry Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Inactivated Poultry Vaccine Revenue Market Share by Company (2020-2022)

Table 19. Global Inactivated Poultry Vaccine Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Inactivated Poultry Vaccine Producing Area Distribution and Sales Area

Table 21. Players Inactivated Poultry Vaccine Products Offered

Table 22. Inactivated Poultry Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Inactivated Poultry Vaccine Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Inactivated Poultry Vaccine Sales Market Share Geographic Region (2017-2022)

Table 27. Global Inactivated Poultry Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Inactivated Poultry Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Inactivated Poultry Vaccine Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Inactivated Poultry Vaccine Sales Market Share by Country/Region (2017-2022)

Table 31. Global Inactivated Poultry Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Inactivated Poultry Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Inactivated Poultry Vaccine Sales by Country (2017-2022) & (K Units)

Table 34. Americas Inactivated Poultry Vaccine Sales Market Share by Country (2017-2022)

Table 35. Americas Inactivated Poultry Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Inactivated Poultry Vaccine Revenue Market Share by Country (2017-2022)

Table 37. Americas Inactivated Poultry Vaccine Sales by Type (2017-2022) & (K Units)

Table 38. Americas Inactivated Poultry Vaccine Sales Market Share by Type (2017-2022)

Table 39. Americas Inactivated Poultry Vaccine Sales by Application (2017-2022) & (K Units)

Table 40. Americas Inactivated Poultry Vaccine Sales Market Share by Application (2017-2022)

Table 41. APAC Inactivated Poultry Vaccine Sales by Region (2017-2022) & (K Units)

Table 42. APAC Inactivated Poultry Vaccine Sales Market Share by Region (2017-2022)

Table 43. APAC Inactivated Poultry Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Inactivated Poultry Vaccine Revenue Market Share by Region (2017-2022)

Table 45. APAC Inactivated Poultry Vaccine Sales by Type (2017-2022) & (K Units)

Table 46. APAC Inactivated Poultry Vaccine Sales Market Share by Type (2017-2022)

Table 47. APAC Inactivated Poultry Vaccine Sales by Application (2017-2022) & (K Units)

Table 48. APAC Inactivated Poultry Vaccine Sales Market Share by Application (2017-2022)

Table 49. Europe Inactivated Poultry Vaccine Sales by Country (2017-2022) & (K Units)

Table 50. Europe Inactivated Poultry Vaccine Sales Market Share by Country (2017-2022)

Table 51. Europe Inactivated Poultry Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Inactivated Poultry Vaccine Revenue Market Share by Country (2017-2022)

Table 53. Europe Inactivated Poultry Vaccine Sales by Type (2017-2022) & (K Units)

Table 54. Europe Inactivated Poultry Vaccine Sales Market Share by Type (2017-2022)

Table 55. Europe Inactivated Poultry Vaccine Sales by Application (2017-2022) & (K Units)

Table 56. Europe Inactivated Poultry Vaccine Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Inactivated Poultry Vaccine Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Inactivated Poultry Vaccine Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Inactivated Poultry Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Inactivated Poultry Vaccine Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Inactivated Poultry Vaccine Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Inactivated Poultry Vaccine Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Inactivated Poultry Vaccine Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Inactivated Poultry Vaccine Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Inactivated Poultry Vaccine

Table 66. Key Market Challenges & Risks of Inactivated Poultry Vaccine

Table 67. Key Industry Trends of Inactivated Poultry Vaccine

Table 68. Inactivated Poultry Vaccine Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Inactivated Poultry Vaccine Distributors List

Table 71. Inactivated Poultry Vaccine Customer List

Table 72. Global Inactivated Poultry Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Inactivated Poultry Vaccine Sales Market Forecast by Region

Table 74. Global Inactivated Poultry Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Inactivated Poultry Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Inactivated Poultry Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Inactivated Poultry Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Inactivated Poultry Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Inactivated Poultry Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Inactivated Poultry Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Inactivated Poultry Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Inactivated Poultry Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Inactivated Poultry Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Inactivated Poultry Vaccine Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Inactivated Poultry Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Inactivated Poultry Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Inactivated Poultry Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Inactivated Poultry Vaccine Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Inactivated Poultry Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Inactivated Poultry Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Inactivated Poultry Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 92. Zoetis Basic Information, Inactivated Poultry Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 93. Zoetis Inactivated Poultry Vaccine Product Offered

Table 94. Zoetis Inactivated Poultry Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Zoetis Main Business

Table 96. Zoetis Latest Developments

Table 97. Merck Animal Health Basic Information, Inactivated Poultry Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 98. Merck Animal Health Inactivated Poultry Vaccine Product Offered

Table 99. Merck Animal Health Inactivated Poultry Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Merck Animal Health Main Business

Table 101. Merck Animal Health Latest Developments

Table 102. Boehringer Ingelheim Basic Information, Inactivated Poultry Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 103. Boehringer Ingelheim Inactivated Poultry Vaccine Product Offered

Table 104. Boehringer Ingelheim Inactivated Poultry Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Boehringer Ingelheim Main Business

Table 106. Boehringer Ingelheim Latest Developments

Table 107. Elanco Animal Health Basic Information, Inactivated Poultry Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 108. Elanco Animal Health Inactivated Poultry Vaccine Product Offered

Table 109. Elanco Animal Health Inactivated Poultry Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Elanco Animal Health Main Business

Table 111. Elanco Animal Health Latest Developments

Table 112. Phibro Animal Health Basic Information, Inactivated Poultry Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 113. Phibro Animal Health Inactivated Poultry Vaccine Product Offered

Table 114. Phibro Animal Health Inactivated Poultry Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Phibro Animal Health Main Business

Table 116. Phibro Animal Health Latest Developments

Table 117. Virbac Basic Information, Inactivated Poultry Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 118. Virbac Inactivated Poultry Vaccine Product Offered

Table 119. Virbac Inactivated Poultry Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. Virbac Main Business

Table 121. Virbac Latest Developments

Table 122. Hipra Basic Information, Inactivated Poultry Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 123. Hipra Inactivated Poultry Vaccine Product Offered

Table 124. Hipra Inactivated Poultry Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Hipra Main Business

Table 126. Hipra Latest Developments

Table 127. Venkys Basic Information, Inactivated Poultry Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 128. Venkys Inactivated Poultry Vaccine Product Offered

Table 129. Venkys Inactivated Poultry Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Venkys Main Business

Table 131. Venkys Latest Developments

Table 132. Biovet Basic Information, Inactivated Poultry Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 133. Biovet Inactivated Poultry Vaccine Product Offered

Table 134. Biovet Inactivated Poultry Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. Biovet Main Business

Table 136. Biovet Latest Developments

Table 137. Ringpu Biology Basic Information, Inactivated Poultry Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 138. Ringpu Biology Inactivated Poultry Vaccine Product Offered

Table 139. Ringpu Biology Inactivated Poultry Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 140. Ringpu Biology Main Business

Table 141. Ringpu Biology Latest Developments

Table 142. Ceva Corporate Basic Information, Inactivated Poultry Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 143. Ceva Corporate Inactivated Poultry Vaccine Product Offered

Table 144. Ceva Corporate Inactivated Poultry Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 145. Ceva Corporate Main Business

Table 146. Ceva Corporate Latest Developments

Table 147. KM Biologics Basic Information, Inactivated Poultry Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 148. KM Biologics Inactivated Poultry Vaccine Product Offered

Table 149. KM Biologics Inactivated Poultry Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 150. KM Biologics Main Business

Table 151. KM Biologics Latest Developments

Table 152. Vaxxinova Basic Information, Inactivated Poultry Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 153. Vaxxinova Inactivated Poultry Vaccine Product Offered

Table 154. Vaxxinova Inactivated Poultry Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 155. Vaxxinova Main Business

Table 156. Vaxxinova Latest Developments

Table 157. Japfa Comfeed Indonesia Basic Information, Inactivated Poultry Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 158. Japfa Comfeed Indonesia Inactivated Poultry Vaccine Product Offered

Table 159. Japfa Comfeed Indonesia Inactivated Poultry Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 160. Japfa Comfeed Indonesia Main Business

Table 161. Japfa Comfeed Indonesia Latest Developments

Table 162. Nisseiken Basic Information, Inactivated Poultry Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 163. Nisseiken Inactivated Poultry Vaccine Product Offered

Table 164. Nisseiken Inactivated Poultry Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 165. Nisseiken Main Business

Table 166. Nisseiken Latest Developments

List of Figures

Figure 1. Picture of Inactivated Poultry Vaccine

Figure 2. Inactivated Poultry Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Inactivated Poultry Vaccine Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Inactivated Poultry Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Inactivated Poultry Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Liquid Vaccines

Figure 10. Product Picture of Freeze-Dried Vaccines

Figure 11. Global Inactivated Poultry Vaccine Sales Market Share by Type in 2021

Figure 12. Global Inactivated Poultry Vaccine Revenue Market Share by Type (2017-2022)

Figure 13. Inactivated Poultry Vaccine Consumed in Avian Encephalomyelitis

Figure 14. Global Inactivated Poultry Vaccine Market: Avian Encephalomyelitis (2017-2022) & (K Units)

Figure 15. Inactivated Poultry Vaccine Consumed in Chicken Anaemia

Figure 16. Global Inactivated Poultry Vaccine Market: Chicken Anaemia (2017-2022) & (K Units)

Figure 17. Inactivated Poultry Vaccine Consumed in Egg Drop Syndrome

Figure 18. Global Inactivated Poultry Vaccine Market: Egg Drop Syndrome (2017-2022) & (K Units)

Figure 19. Inactivated Poultry Vaccine Consumed in Others

Figure 20. Global Inactivated Poultry Vaccine Market: Others (2017-2022) & (K Units)

Figure 21. Global Inactivated Poultry Vaccine Sales Market Share by Application (2017-2022)

Figure 22. Global Inactivated Poultry Vaccine Revenue Market Share by Application in 2021

Figure 23. Inactivated Poultry Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Inactivated Poultry Vaccine Revenue Market Share by Company in 2021

Figure 25. Global Inactivated Poultry Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Inactivated Poultry Vaccine Revenue Market Share by Geographic Region in 2021

Figure 27. Global Inactivated Poultry Vaccine Sales Market Share by Region (2017-2022)

Figure 28. Global Inactivated Poultry Vaccine Revenue Market Share by Country/Region in 2021

Figure 29. Americas Inactivated Poultry Vaccine Sales 2017-2022 (K Units)

Figure 30. Americas Inactivated Poultry Vaccine Revenue 2017-2022 ($ Millions)

Figure 31. APAC Inactivated Poultry Vaccine Sales 2017-2022 (K Units)

Figure 32. APAC Inactivated Poultry Vaccine Revenue 2017-2022 ($ Millions)

Figure 33. Europe Inactivated Poultry Vaccine Sales 2017-2022 (K Units)

Figure 34. Europe Inactivated Poultry Vaccine Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Inactivated Poultry Vaccine Sales 2017-2022 (K Units)

Figure 36. Middle East & Africa Inactivated Poultry Vaccine Revenue 2017-2022 ($ Millions)

Figure 37. Americas Inactivated Poultry Vaccine Sales Market Share by Country in 2021

Figure 38. Americas Inactivated Poultry Vaccine Revenue Market Share by Country in 2021

Figure 39. United States Inactivated Poultry Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Inactivated Poultry Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Inactivated Poultry Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Inactivated Poultry Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Inactivated Poultry Vaccine Sales Market Share by Region in 2021

Figure 44. APAC Inactivated Poultry Vaccine Revenue Market Share by Regions in 2021

Figure 45. China Inactivated Poultry Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Inactivated Poultry Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Inactivated Poultry Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Inactivated Poultry Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Inactivated Poultry Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Inactivated Poultry Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Inactivated Poultry Vaccine Sales Market Share by Country in 2021

Figure 52. Europe Inactivated Poultry Vaccine Revenue Market Share by Country in 2021

Figure 53. Germany Inactivated Poultry Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Inactivated Poultry Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Inactivated Poultry Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Inactivated Poultry Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Inactivated Poultry Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Inactivated Poultry Vaccine Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Inactivated Poultry Vaccine Revenue Market Share by Country in 2021

Figure 60. Egypt Inactivated Poultry Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Inactivated Poultry Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Inactivated Poultry Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Inactivated Poultry Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Inactivated Poultry Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Inactivated Poultry Vaccine in 2021

Figure 66. Manufacturing Process Analysis of Inactivated Poultry Vaccine

Figure 67. Industry Chain Structure of Inactivated Poultry Vaccine

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390